Changshan Pharma and ConjuChem Form $3 Million Diabetes JV

Published: Nov 20, 2012

by Richard Daverman, PhD

November 19, 2012 -- Hebei Changshan Biochemical Pharma will form a JV with ConjuChem LLC, a privately owned Los Angeles company that is developing a long-acting form of insulin. The JV will work towards gaining SFDA approval for the product in China. ConjuChem is owned by Dr. Patrick Soon-Shiong, the man behind the very successful cancer drug Abraxane®. Abraxane is a form of paclitaxel that allows more of the drug’s active ingredient to reach the tumor. More details....

Stock Symbol: (SHE: 300255)

Back to news